DNA Microarrays
RNA-seq
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 4, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
Ina A Eilertsen1, Seyed H Moosavi1, Jonas M Strømme2
1Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway; K. G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, P.O. Box 4953, Nydalen, NO-0424, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, P.O. Box 1171 Blindern, NO-0318, Oslo, Norway.
Comparing RNA sequencing and microarrays for colorectal cancer (CRC) subtyping revealed platform-specific biases. Assay standardization and careful gene selection are crucial for clinical translation of transcriptomic CRC subtyping.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: